BioMed is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2021. The journal covers Chemical technology: Biotechnology and Medicine.
Authors are required to pay an article processing charge to publish in BioMed; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
clinical medicine, basic medical science, public health, biomedical engineering, biotechnology, cardiology and cardiovascular medicine
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2021
ISSN
- electronic
- 2673-8430
Frequently asked questions
Is BioMed peer-reviewed?
Yes — BioMed operates a Anonymous peer review review process.
Does BioMed charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does BioMed publish?
BioMed publishes research in Chemical technology: Biotechnology and Medicine.
What languages does BioMed accept?
BioMed accepts manuscripts in English.
What is the ISSN of BioMed?
ISSN:
2673-8430 (electronic).How do I submit a manuscript to BioMed?
Submit through the journal's official portal: visit submission page →